I think any partner/ Pharma would say we are interested but do something with this debenture that could own your molecules etc. It would be the optics for them, not the $ amount. Come back when you have that.  COVID  is a given for the delay, agreed but hasn't stopped others with a plan and Funds. I venture to gain that if we do have some serious partner in the wings that they now can line-up their ducks and get on with some serious discussions and papers and let the lawyers loose. Dovetail the BTD and suggestions by FDA. and this time come up with a comprehensive trial to hit the right milestone for success. It seems to me the FDA  is willing to guide them in that direction. Mind you they have had the time to craft the same already. They can do a quick PP to fill the coffers and clear up payables or get upfront money from whomever is playing and maybe that is what convinced ORI to Extend. DM may not be the best Maestro for the job but he is the only one we have and I bet he is a good poker player. 

So bottom line, IMO we are going higher soon. Not the homerun higher as no buyout until RVX hits the right P-value they are testing for.  We could wake up one morning and read someone like Pfizer is ready to play because of the BTD the timing would work.